HEERMA PETER (Chief Commercial Officer) sold 5.3% of their position (7.31K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $234.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/3/2026ACC: 0001789617-26-000001
Officer· Chief Commercial Officer
Since Oct 2019
+88.45K
Net shares
Net buyer
$234.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
95.76K acquired · 7.31K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+26.12K
Price / share
—
Trade value
—
% of position
23.1%
1/31/2026
113.01K→139.13K
Common Stock
Direct
Shares
−7.31K
Price / share
$32.12
Trade value
$234.80K
% of position
5.3%
2/3/2026
139.13K→131.82K
Total
Net shares
+18.81K
Net value
-$234.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2026 | A · Award | +26.12K | — | — | 23.1% | 113.01K | 139.13K |
| Common Stock Direct | 2/3/2026 | S · Sale | −7.31K | $32.12 | $234.80K | 5.3% | 139.13K | 131.82K |
| Total | +18.81K | -$234.80K | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
69.64K shares
Shares
+69.64K
Strike price
33.095
Held after
69.64K
Exercisable
—
1/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock69.64K shares | 1/31/2026 | A · Award | +69.64K | 33.095 | — | 69.64K |